False positive mammogram breast cancer risk may be higher than previously understood. A major analysis involving nearly 4.9 million women found a 77% higher relative rate of subsequent breast cancer. Understand what this finding means, why a false positive does not cause cancer, and how personalised screening and risk assessment may help guide future care.

FDA mammogram warning guidance explains what patients should do when previous breast screening may not meet required quality standards. Learn when an independent image review is needed, when repeat mammography may be recommended, which breast symptoms require prompt assessment, and how to choose a certified mammography facility.